LYSO-VAC develops and markets therapies and vaccines against infectious diseases as AIDS and hepatitis C. Lyso-vac’s agents take advantage of the specificity of antibodiesas as well as the patient’s immune response. The new technology makes the development of antibody therapies against illnesses for which there have so far been no treatment options possible.
